• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
SAVE 25% OFF ALL REPORTS — USE CODE "25OFFQ4" DURING CHECKOUT — ENDS DECEMBER 31
  • 0Shopping Cart

  • COVID-19 Resources
  • Blog
  • Featured
    • View Webinars On-Demand
    • The In Vitro Diagnostics Market: $83 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • Free Downloads
  • About Us
  • Research Index
  • Contact
  • Search
  • Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
The 80-Billion Dollar IVD Market: Five Fast Facts from New Report
September 14, 2020
IVD Market Reaches 83 Billion, Says New Report
August 31, 2020
Could COVID-19 Influence Lab-Developed Tests Regulation?
July 10, 2020
Comprehensive Database of Clinical Diagnostics Equipment Now Available
July 2, 2020
COVID-19 Has Small Negative Impact on Market for Companion Diagnostics: Kalorama
June 26, 2020
Chagas Disease Threat: Better Diagnostics Sought, U.S. Department of Defense Gets Involved.
June 26, 2020
COVID-19 Crisis Puts Spotlight on Use of Immunoassay Tests
June 18, 2020
New Report Profiles Over 90 Significant Competitors in Point-of-Care Testing
May 21, 2020
Multi-Billion Dollar Potential Market for COVD-19 Vaccine, Per Market Research Firm
May 20, 2020
Telehealth Thrives Amid Social Distancing, COVID-19 Crisis
May 13, 2020

Most Popular Research

  • The Worldwide Market for In Vitro Diagnostics, 13th Edition
  • Clinical Diagnostics MasterFile
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Urgent Care and Its Enemies November 25, 2020
  • Siemens Healthineers Announces COVID-19 Neutralizing Antibodies Test November 19, 2020
  • Vaccines Won’t Eliminate the Need for COVID-19 Testing November 18, 2020
  • COVID-19 Diagnostics Blog: Antigen Testing Takes Center Stage; New Qiagen Test; Hologic and BD Sales Boom; CMS Cuts Payments to Spur Lab Turnaround; AMP Survey November 11, 2020
  • Vaccine Market Grows to 37.4 BN November 9, 2020

Sitemap

  • Home
  • About
  • Blog
  • Contact

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register